Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SANUWAVE Health (SNWV) Total Current Liabilities (2023 - 2025)

SANUWAVE Health (SNWV) has disclosed Total Current Liabilities for 9 consecutive years, with $17.8 million as the latest value for Q4 2025.

  • Quarterly Total Current Liabilities fell 60.71% to $17.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $17.8 million through Dec 2025, down 60.71% year-over-year, with the annual reading at $17.8 million for FY2025, 60.71% down from the prior year.
  • Total Current Liabilities for Q4 2025 was $17.8 million at SANUWAVE Health, down from $24.0 million in the prior quarter.
  • The five-year high for Total Current Liabilities was $85.4 million in Q3 2023, with the low at $17.8 million in Q4 2025.
  • Average Total Current Liabilities over 3 years is $58.4 million, with a median of $62.4 million recorded in 2023.
  • The sharpest move saw Total Current Liabilities fell 0.66% in 2024, then plummeted 70.58% in 2025.
  • Over 3 years, Total Current Liabilities stood at $64.8 million in 2023, then fell by 29.85% to $45.4 million in 2024, then tumbled by 60.71% to $17.8 million in 2025.
  • According to Business Quant data, Total Current Liabilities over the past three periods came in at $17.8 million, $24.0 million, and $50.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.